Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
0.8973
Dollar change
+0.0732
Percentage change
8.88
%
IndexRUT P/E- EPS (ttm)-0.26 Insider Own7.74% Shs Outstand158.86M Perf Week19.59%
Market Cap142.75M Forward P/E14.17 EPS next Y0.06 Insider Trans0.00% Shs Float146.79M Perf Month14.19%
Income-39.33M PEG- EPS next Q-0.05 Inst Own16.96% Short Float8.30% Perf Quarter13.70%
Sales0.00M P/S- EPS this Y1.52% Inst Trans-7.58% Short Ratio18.32 Perf Half Y29.76%
Book/sh0.53 P/B1.68 EPS next Y129.23% ROA-36.52% Short Interest12.18M Perf Year-12.88%
Cash/sh0.13 P/C7.01 EPS next 5Y- ROE-41.24% 52W Range0.60 - 1.71 Perf YTD18.61%
Dividend Est.- P/FCF- EPS past 5Y28.21% ROI-46.31% 52W High-47.53% Beta1.44
Dividend TTM- Quick Ratio5.06 Sales past 5Y0.00% Gross Margin- 52W Low49.55% ATR (14)0.06
Dividend Ex-Date- Current Ratio5.06 EPS Y/Y TTM-33.02% Oper. Margin0.00% RSI (14)68.78 Volatility9.03% 7.50%
Employees22 Debt/Eq0.01 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price5.33
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q-136.18% Payout- Rel Volume1.92 Prev Close0.82
Sales Surprise-100.00% EPS Surprise-146.15% Sales Q/Q- EarningsFeb 14 AMC Avg Volume664.94K Price0.90
SMA2019.52% SMA5024.54% SMA2006.25% Trades Volume1,273,373 Change8.88%
Date Action Analyst Rating Change Price Target Change
Nov-30-21Initiated Maxim Group Buy $4
Mar-18-24 08:30AM
Mar-12-24 10:30AM
Mar-07-24 08:30AM
Feb-26-24 07:30AM
Feb-23-24 08:30AM
09:17AM Loading…
Feb-15-24 09:17AM
Feb-14-24 04:30PM
08:01AM
Jan-23-24 08:30AM
Jan-02-24 08:31AM
08:30AM
Nov-14-23 08:55AM
Nov-09-23 08:30AM
Oct-31-23 08:45AM
Oct-24-23 07:30AM
09:35AM Loading…
Sep-21-23 09:35AM
Sep-18-23 04:30PM
Sep-13-23 04:30PM
Sep-08-23 08:00AM
Sep-06-23 04:30PM
Aug-14-23 04:15PM
Aug-10-23 08:37AM
Jul-29-23 04:16PM
Jun-26-23 08:30AM
Jun-20-23 04:09PM
08:30AM
Jun-13-23 08:30AM
May-12-23 04:30PM
May-08-23 01:42PM
May-04-23 08:00AM
09:10AM Loading…
Apr-24-23 09:10AM
Apr-03-23 08:00AM
Mar-30-23 08:30AM
Mar-27-23 09:52AM
Mar-13-23 09:15AM
Mar-08-23 08:30AM
Feb-10-23 04:30PM
Feb-06-23 10:30AM
Jan-17-23 10:00AM
Jan-16-23 07:09AM
Jan-11-23 08:30AM
Dec-28-22 09:35AM
Dec-22-22 04:30PM
Dec-01-22 07:30AM
Nov-21-22 08:00AM
Nov-09-22 08:30AM
Oct-18-22 08:30AM
07:59AM
Oct-06-22 04:30PM
Sep-28-22 08:30AM
Sep-23-22 06:48AM
Sep-22-22 04:30PM
Sep-15-22 08:30AM
Sep-08-22 04:30PM
Sep-07-22 08:30AM
Aug-11-22 04:31PM
Aug-09-22 07:24AM
Jul-12-22 08:07AM
May-25-22 10:13AM
08:47AM
May-18-22 09:30AM
May-12-22 04:30PM
May-11-22 07:34AM
May-10-22 11:10AM
May-08-22 09:00AM
May-06-22 09:37AM
May-03-22 10:06AM
Apr-26-22 08:30AM
Apr-14-22 09:25AM
Apr-13-22 09:25AM
Apr-07-22 09:57AM
Apr-06-22 08:14AM
06:50AM
Mar-29-22 10:18AM
Mar-03-22 09:15AM
Mar-02-22 04:12AM
Feb-15-22 09:15AM
Feb-10-22 04:30PM
Jan-04-22 09:00AM
Dec-15-21 04:30PM
Dec-06-21 09:15AM
Dec-02-21 05:17AM
Nov-05-21 09:15AM
Oct-25-21 09:15AM
Oct-13-21 11:38AM
Oct-06-21 10:40AM
Oct-04-21 12:31PM
Oct-01-21 08:30AM
Sep-23-21 12:12PM
Sep-16-21 10:38AM
Sep-14-21 10:06AM
Sep-08-21 11:34AM
09:15AM
Sep-07-21 07:30AM
Aug-12-21 04:30PM
Aug-04-21 10:34AM
Aug-03-21 04:29PM
Jul-20-21 07:17AM
Jul-07-21 07:15PM
12:30PM
Citius Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of critical care products, with a focus on oncology, anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. Its products include I/ONTAK, Mino-Lok, Halo-Lido, Mino-Wrap, and Novecite. The company was founded by Ralph Montrone on January 23, 2007 and is headquartered in Cranford, NJ.